|
Jun 20
|
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
|
|
Jun 20
|
AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
|
|
Jun 19
|
Here's Why AbbVie (ABBV) is a Strong Momentum Stock
|
|
Jun 19
|
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
|
|
Jun 19
|
2 Super Smart Dividend Stocks to Buy With $10,000 Right Now
|
|
Jun 19
|
AbbVie’s SKYRIZI gains US FDA approval for ulcerative colitis
|
|
Jun 18
|
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease
|
|
Jun 18
|
Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression
|
|
Jun 18
|
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
|
|
Jun 18
|
Humira: the highs and lows of the world’s best-selling drug
|
|
Jun 16
|
2 Dividend Stocks That Could Pay You for Life
|
|
Jun 14
|
AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer
|
|
Jun 14
|
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
|
|
Jun 14
|
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
|
|
Jun 14
|
AbbVie joins in latest gastrointestinal drug chase
|
|
Jun 14
|
AbbVie and FutureGen link on inflammatory bowel disease
|
|
Jun 13
|
Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends
|
|
Jun 13
|
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease
|
|
Jun 11
|
BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients
|
|
Jun 7
|
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
|